Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

11
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
11
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

19
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
19
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

276
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
276
Contaminants and Errors01:16

Contaminants and Errors

392
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
392
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

527
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
527
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

628
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Preliminary results of a program for the implementation of laparoscopic colorectal surgery in an Italian comprehensive cancer center during the COVID-19 pandemic.

Updates in surgery·2022
Same author

A multi-national survey of experience and attitudes towards commencing home parenteral nutrition for patients with advanced cancer.

Clinical nutrition ESPEN·2022
Same author

Suboptimal nutritional support in cancer patients gets excellent results. Reply to the Letter to the Editor: 'Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial' by L. Bargetzi et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Does nutrition for cancer patients feed the tumour? A clinical perspective.

Critical reviews in oncology/hematology·2020
Same author

Observation of Single Top Quark Production in Association with a Z Boson in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2019

Related Experiment Video

Updated: Feb 15, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.5K

Catheter sepsis from infusate contamination.

F Bozzetti, G Bonfanti, E Regalia

    Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
    |August 1, 1990
    PubMed
    Summary

    Infusate contamination in patients with central venous catheters (CVCs) can lead to sepsis. Strict aseptic techniques during intravenous solution preparation are crucial for preventing this potentially lethal complication, especially with opportunistic pathogens like S. epidermidis.

    More Related Videos

    Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
    06:40

    Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

    Published on: February 9, 2014

    29.2K
    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
    07:34

    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

    Published on: April 11, 2012

    20.1K

    Related Experiment Videos

    Last Updated: Feb 15, 2026

    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
    04:01

    Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

    Published on: June 14, 2024

    1.5K
    Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
    06:40

    Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

    Published on: February 9, 2014

    29.2K
    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
    07:34

    Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

    Published on: April 11, 2012

    20.1K

    Area of Science:

    • Clinical Medicine
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Indwelling central venous catheters (CVCs) are essential for patient care but pose risks for infection.
    • Infusate contamination, often by opportunistic pathogens, is a serious concern in patients with CVCs.
    • Staphylococcus epidermidis is frequently implicated due to its affinity for prosthetic devices and the compromised state of some patients.

    Purpose of the Study:

    • To describe cases of infusate contamination in patients with CVCs.
    • To identify the microorganisms responsible for contamination and subsequent sepsis.
    • To emphasize the importance of aseptic technique in preventing infusate-related sepsis.

    Main Methods:

    • Retrospective case series describing ten patients with CVCs and contaminated infusate.
    • Microbiological analysis of infusate contaminants.
    • Clinical assessment of sepsis development and outcomes.

    Main Results:

    • Six out of ten patients developed sepsis; one patient died from septic shock.
    • Opportunistic pathogens were the main contaminants, with Staphylococcus epidermidis identified in five cases.
    • No direct correlation was found between infusate contamination rate and sepsis incidence.

    Conclusions:

    • Infusate contamination is a significant risk factor for sepsis in CVC patients.
    • Staphylococcus epidermidis is a prevalent pathogen in these cases.
    • Strict adherence to aseptic techniques during the preparation and handling of intravenous solutions is critical for prevention.